Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study-Reference-Cited by-同舟云学术

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

Published:2010-11-15 Issue:1 Volume:86 Page:23-31
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Dimopoulos Meletios A.,Mateos Maria-Victoria,Richardson Paul G.,Schlag Rudolf,Khuageva Nuriet K.,Shpilberg Ofer,Kropff Martin,Spicka Ivan,Palumbo Antonio,Wu Ka Lung,Esseltine Dixie-Lee,Liu Kevin,Deraedt William,Cakana Andrew,Van De Velde Helgi,San Miguel Jesús F.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2010.01533.x/fullpdf

Reference36 articles.

1. Neurological aspects of multiple myeloma and related disorders;Dispenzieri;Best Pract Res Clin Haematol,2005

2. The spectrum of peripheral neuropathy in myeloma;Kelly;Neurology,1981

3. Neuropathies associated with paraproteinemia;Ropper;N Engl J Med,1998

4. Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board;Tariman;Clin J Oncol Nurs,2008

5. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlates of response and neuropathy;Richardson;J Clin Oncol,2009

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma;American Journal of Hematology;2024-09-10

2. Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea;The Journal of Pain;2024-09

3. Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach;Critical Reviews in Oncology/Hematology;2024-05

4. The Current State of Integrated Treatment with Chinese and Western Medicine for Nerve Damage Associated with Multiple Myeloma;Advances in Clinical Medicine;2024

5. Genetic risk factors for bortezomib-induced peripheral neuropathy in an Asian population: A genome-wide association study in South Korea;2023-10-18